These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25613381)

  • 1. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
    Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
    Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs.
    Wilms C; Krikki I; Hainzl A; Kilo S; Alupei M; Makrantonaki E; Wagner M; Kroeger CM; Brinker TJ; Gatzka M
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
    Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
    Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
    Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
    FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
    Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
    Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8
    Förster M; Boora RK; Petrov JC; Fodil N; Albanese I; Kim J; Gros P; Nijnik A
    Immunology; 2017 May; 151(1):110-121. PubMed ID: 28066899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.
    Le Guen T; Touzot F; André-Schmutz I; Lagresle-Peyrou C; France B; Kermasson L; Lambert N; Picard C; Nitschke P; Carpentier W; Bole-Feysot C; Lim A; Cavazzana M; Callebaut I; Soulier J; Jabado N; Fischer A; de Villartay JP; Revy P
    J Allergy Clin Immunol; 2015 Dec; 136(6):1619-1626.e5. PubMed ID: 26220525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
    Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
    Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
    Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
    Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
    Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A
    Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of B cell development by the histone H2A deubiquitinase MYSM1.
    Jiang XX; Nguyen Q; Chou Y; Wang T; Nandakumar V; Yates P; Jones L; Wang L; Won H; Lee HR; Jung JU; Müschen M; Huang XF; Chen SY
    Immunity; 2011 Dec; 35(6):883-96. PubMed ID: 22169041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
    Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.
    Wilms C; Kroeger CM; Hainzl AV; Banik I; Bruno C; Krikki I; Farsam V; Wlaschek M; Gatzka MV
    Oncotarget; 2017 Sep; 8(40):67287-67299. PubMed ID: 28978033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival.
    Huo Y; Li BY; Lin ZF; Wang W; Jiang XX; Chen X; Xi WJ; Yang AG; Chen SY; Wang T
    Med Sci Monit; 2018 Apr; 24():2541-2549. PubMed ID: 29694335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow.
    Förster M; Belle JI; Petrov JC; Ryder EJ; Clare S; Nijnik A
    Stem Cells Dev; 2015 Aug; 24(16):1865-77. PubMed ID: 26125289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mysm1 is required for interferon regulatory factor expression in maintaining HSC quiescence and thymocyte development.
    Huang XF; Nandakumar V; Tumurkhuu G; Wang T; Jiang X; Hong B; Jones L; Won H; Yoshii H; Ozato K; Masumi A; Chen SY
    Cell Death Dis; 2016 Jun; 7(6):e2260. PubMed ID: 27277682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
    Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
    Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.
    Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance.
    Petrov JC; Nijnik A
    Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.
    Bahrami E; Witzel M; Racek T; Puchałka J; Hollizeck S; Greif-Kohistani N; Kotlarz D; Horny HP; Feederle R; Schmidt H; Sherkat R; Steinemann D; Göhring G; Schlegelbeger B; Albert MH; Al-Herz W; Klein C
    J Allergy Clin Immunol; 2017 Oct; 140(4):1112-1119. PubMed ID: 28115216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.